These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 8856472

  • 1. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T, Carlsson L, Scherlag BJ, Mabo P, Poty H, Palmer M, Patterson E, Berlin KD, Garrison GL, Lazzara R.
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiological characterization of a novel class III antiarrhythmic agent, GLG-V-13 in the mammalian heart.
    Fazekas T, Scherlag BJ, Carlsson L, Mabo P, Patterson E, Berlin KD, Lazzara R.
    Acta Physiol Hung; 1995 Aug; 83(1):13-30. PubMed ID: 7660832
    [Abstract] [Full Text] [Related]

  • 3. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.
    Pankucsi C, Bányász T, Magyar J, Gyönös I, Kovács A, Varró A, Szénási G, Nánási PP.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672
    [Abstract] [Full Text] [Related]

  • 4. The comparative antiarrhythmic and proarrhythmic activity of a 3,7-diheterobicyclo[3.3.1]nonane, BRB-I-28, and lidocaine in the 1-4-day-old infarcted dog heart.
    Fazekas T, Scherlag BJ, Mabo P, Berlin KD, Garrison GL, Chen CL, Sangiah S, Patterson E, Lazzara R.
    Acta Physiol Hung; 1993 Mar; 81(3):289-99. PubMed ID: 8197884
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea-pig, rabbit and canine cardiac preparations.
    Sunami A, Sawanobori T, Adaniya H, Hiraoka M.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):323-30. PubMed ID: 1961258
    [Abstract] [Full Text] [Related]

  • 6. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
    Lynch JJ, Wallace AA, Van der Gaag LH, Baskin EP, Bear CM, Gehret JR, Kothstein T, Stupienski RF, Appleby SD, Sanguinetti MC.
    J Pharmacol Exp Ther; 1993 May; 265(2):720-30. PubMed ID: 8496818
    [Abstract] [Full Text] [Related]

  • 7. Electrophysiologic actions of d,l-sotalol and GLG-V-13 in ischemically injured canine epicardium.
    Patterson E, Scherlag BJ, Lazzara R, Garrison GL, Berlin KD.
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):304-13. PubMed ID: 17878760
    [Abstract] [Full Text] [Related]

  • 8. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
    Lynch JJ, Wallace AA, Stupienski RF, Baskin EP, Beare CM, Appleby SD, Salata JJ, Jurkiewicz NK, Sanguinetti MC, Stein RB.
    J Pharmacol Exp Ther; 1994 May; 269(2):541-54. PubMed ID: 7802864
    [Abstract] [Full Text] [Related]

  • 9. Class III electrophysiologic actions of imidazole-substituted diheterabicyclononanes in canine myocardium.
    Patterson E, Scherlag BJ, Sangiah S, Garrison GL, Couch KM, Berlin KD, Lazzara R.
    J Pharmacol Exp Ther; 1997 Apr; 281(1):155-62. PubMed ID: 9103493
    [Abstract] [Full Text] [Related]

  • 10. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
    Leboeuf J, Basiez M, Massingham R.
    Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
    [Abstract] [Full Text] [Related]

  • 11. Effect of GLG-V-13, a class III antiarrhythmic agent, on potassium currents in rabbit ventricular myocytes.
    Virág L, Fazekas T, Iost N, Varró A, Berlin KD, Scherlag BJ, Lazzara R, Pap JG.
    Life Sci; 2000 Mar; 66(17):PL 253-8. PubMed ID: 11261597
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent, in canine isolated ventricular muscle and purkinje fibers.
    Baláti B, Iost N, Simon J, Varró A, Papp JG.
    Gen Pharmacol; 2000 Feb; 34(2):85-93. PubMed ID: 10974415
    [Abstract] [Full Text] [Related]

  • 13. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
    Wallace AA, Stupienski RF, Baskin EP, Appleby SD, Kothstein T, Gehret JR, King SW, Remy DC, Lynch JJ.
    J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiologic actions of BRB-I-28 in ischemically injured canine myocardium.
    Patterson E, Scherlag BJ, Berlin KD, Lazzara R.
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):637-46. PubMed ID: 7681911
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y, Kawada M, Sawanobori K, Sonoki H, Inoue K, Mizuno K, Itou T, Tabunoki Y, Tsukamoto M, Ohashi Y, Kyotani Y, Shimizu N, Fujii M, Nakamura M.
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [Abstract] [Full Text] [Related]

  • 16. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
    Chang GJ, Su MJ, Kuo SC, Lin TP, Lee YS.
    J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797
    [Abstract] [Full Text] [Related]

  • 17. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
    Damiano BP, Stump GL, Yagel SK.
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent.
    Gwilt M, Dalrymple HW, Burges RA, Blackburn KJ, Dickinson RP, Cross PE, Higgins AJ.
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):376-85. PubMed ID: 1711597
    [Abstract] [Full Text] [Related]

  • 19. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
    Malfatto G, Zaza A, Forster M, Sodowick B, Danilo P, Rosen MR.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440
    [Abstract] [Full Text] [Related]

  • 20. Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia.
    Millar JS, Vaughan Williams EM.
    Br J Pharmacol; 1982 Mar; 75(3):469-78. PubMed ID: 7066601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.